Prevalence of occult hepatitis B virus infection

被引：0

作者：

Luisa Gutierrez-Garcia, Maria ^{[1
]}

Fernandez-Rodriguez, Conrado M. ^{[1
]}

Luis Lledo-Navarro, Jose ^{[1
]}

Buhigas-Garcia, Ingrid

机构：

[1] Hosp Univ Fdn Alcorcon, Serv Gastroenterol, Madrid 28922, Spain

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2011年 / 17卷 / 12期

关键词：

Occult hepatitis B virus infection; Hepatitis B virus DNA; Anti-HBc; Hepatitis B virus seronegative; Hepatitis C; Crytogenetic hepatitis; Dialysis; Human immunodeficiency virus; Blood donors; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC HCV INFECTION; ACID TESTING ASSAY; HEMODIALYSIS-PATIENTS; C-VIRUS; BLOOD-DONORS; CORE ANTIGEN; SURFACE-ANTIGEN; HBV INFECTION; ANTIRETROVIRAL THERAPY;

D O I：

10.3748/wjg.v17.i12.1538

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Occult hepatitis B virus (HBV) infection (OBI) is characterized by the persistence of HBV DNA in the liver tissue in individuals negative for the HBV surface antigen. The prevalence of OBI is quite variable depending on the level of endemic disease in different parts of the world, the different assays utilized in the studies, and the different populations studied. Many studies have been carried out on OBI prevalence in different areas of the world and categories of individuals. The studies show that OBI prevalence seems to be higher among subjects at high risk for HBV infection and with liver disease than among individuals at low risk of infection and without liver disease. (C) 2011 Baishideng. All rights reserved.

引用

页码：1538 / 1542

页数：5

共 46 条

[1] Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion [J].

Allain, JP ;

Hewitt, PE ;

Tedder, RS ;

Williamson, LM .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :186-195

[2] Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology [J].

Berasain, C ;

Betés, M ;

Panizo, A ;

Ruiz, J ;

Herrero, JI ;

Civeira, MP ;

Prieto, J .

GUT, 2000, 47 (03) :429-435

[3] Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection [J].

Besisik, F ;

Karaca, Q ;

Akyüz, F ;

Horosanli, S ;

Önel, D ;

Badur, S ;

Sever, MS ;

Danalioglu, A ;

Demir, K ;

Kaymakoglu, S ;

Çakaloglu, Y ;

Ökten, A .

JOURNAL OF HEPATOLOGY, 2003, 38 (04) :506-510

[4] Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice [J].

Bhatti, Farhat Abbas ;

Ullah, Zia ;

Salamat, Nuzhat ;

Ayub, Muhammad ;

Ghani, Ejaz .

TRANSFUSION, 2007, 47 (01) :74-79

[5] Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].

Bréchot, C ;

Thiers, V ;

Kremsdorf, D ;

Nalpas, B ;

Pol, S ;

Paterlini-Bréchot, P .

HEPATOLOGY, 2001, 34 (01) :194-203

[6] Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT [J].

Brojer, Ewa ;

Grabarczyk, Piotr ;

Liszewski, Grzegorz ;

Mikulska, Maria ;

Allain, Jean-Pierre ;

Letowska, Magdalena .

HEPATOLOGY, 2006, 44 (06) :1666-1674

[7] Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].

Cacciola, I ;

Pollicino, T ;

Squadrito, G ;

Cerenzia, G ;

Orlando, ME ;

Raimondo, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26

[8] High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology [J].

Chemin, I ;

Zoulim, F ;

Merle, P ;

Arkhis, A ;

Chevallier, M ;

Kay, A ;

Cova, L ;

Chevallier, P ;

Mandrand, B ;

Trépo, C .

JOURNAL OF HEPATOLOGY, 2001, 34 (03) :447-454

[9] Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay [J].

Chevrier, Marie-Claire ;

St-Louis, Maryse ;

Perreault, Josee ;

Caron, Brigitte ;

Castilloux, Cindy ;

Laroche, Jerome ;

Delage, Gilles .

TRANSFUSION, 2007, 47 (10) :1794-1802

[10] Occult hepatitis B virus infection in dialysis patients: a multicentre survey [J].

Fabrizi, F ;

Messa, PG ;

Lunghi, G ;

Aucella, F ;

Bisegna, S ;

Mangano, S ;

Villa, M ;

Barbisoni, F ;

Rusconi, E ;

Martin, P .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (11) :1341-1347

← 1 2 3 4 5 →